Sabra Healthcare REIT, Inc. (SBRA) is a publicly traded Real Estate sector company. As of October 19, 2026, SBRA trades at $19.10 with a market cap of $4.94B and a P/E ratio of 75.50. SBRA moved -1.24% today. Year to date, SBRA is +2.11%; over the trailing twelve months it is +8.65%. Its 52-week range spans $15.75 to $22.77. Analyst consensus is buy with an average price target of $22.73. Rallies surfaces SBRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SBRA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SBRA recently traded at $19.10. Market cap is $4.94B. P/E ratio is 75.50. Revenue is $859.56M.
| Metric | Value |
|---|---|
| Price | $19.10 |
| Market Cap | $4.94B |
| P/E Ratio | 75.50 |
| EPS | $0.25 |
| Dividend Yield | 0.30% |
| 52-Week High | $22.77 |
| 52-Week Low | $15.75 |
| Volume | 1 |
| Avg Volume | 0 |
| Revenue (TTM) | $859.56M |
| Net Income | $65.23M |
| Gross Margin | 0.00% |
12 analysts cover SBRA: 0 strong buy, 6 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $22.73.